<DOC>
	<DOCNO>NCT02919072</DOCNO>
	<brief_summary>The study evaluate quality epidural anaesthesia safety Chloroprocaine HCl 3 % compare Ropivacaine HCl 0.75 % patient epidural catheter situ undergo unplanned Caesarean section .</brief_summary>
	<brief_title>Chloroprocaine 3 % - Epidural</brief_title>
	<detailed_description>Labouring woman epidural catheter situ establish analgesia , need unplanned Caesarean section , randomly allocate receive either Chloroprocaine HCl 3 % ( T-group ) Ropivacaine HCl 0.75 % ( R-group ) epidurally . Prior epidural injection , patient transfer operating theatre . The local anaesthetic solution freshly prepare 20 mL administer epidural injection , accord standard hospital procedure , detail `` Study Schedule '' section . Time T0 define start time first epidural injection investigational product . In case pain discomfort , 6 mL epidural top-up anaesthetic , i.e . Chloroprocaine HCl 3 % T-group Ropivacaine HCl 0.75 % R-group , administer . The anaesthesiologist ( ) administer anaesthetic collect data blind respect treatment give patient .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Chloroprocaine</mesh_term>
	<mesh_term>Procaine</mesh_term>
	<criteria>1 . Informed consent : Signed write informed consent inclusion study ( obtain woman fulfil criterion , effective analgesia establish ) 2 . Sex , pregnancy status age : Labouring woman singleton pregnancy , ≥ 18 year old 3 . Epidural catheter : Previously sit epidural catheter 4 . ASA physical status : III 5 . Analgesia : Effective analgesia establish follow combine spinal epidural analgesia ( CSE ) 6 . Term gestation : ≥ 36 week 7 . Caesarean section : Unplanned Caesarean section category 2 3 , accord Lucas Classification 8 . Body Mass Index ( BMI ) : ≤ 40 kg/m2 9 . Full comprehension : ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate investigator comply requirement entire study . 1 . Physical finding : Clinically significant abnormal physical finding could interfere objective study . Contraindications epidural anaesthesia 2 . ASA physical status : IIIV 3 . Further anaesthesia : Patients expect require anaesthesia 4 . Epidural catheter : Epidural catheter failure ( epidural catheter replacement require inability provide effective analgesia ) 5 . Pregnancy : Labouring woman multiple pregnancy 6 . Caesarean section : Elective Caesarean section 7 . Allergy : ascertain presumptive hypersensitivity active principle /or formulation ingredient ; ascertain presumptive hypersensitivity amide estertype anaesthetic 8 . Diseases : significant history renal , hepatic , gastrointestinal , cardiovascular , respiratory , skin , haematological , endocrine neurological disease may interfere aim study ; ascertain psychiatric disease , eclampsia , antepartum haemorrhage , sepsis , blood coagulation disorder , insulin dependent diabetes mellitus , terminal kidney failure 9 . Medications : Medication know interfere extent regional block ( see chloroprocaine ropivacaine SmPCs ) 2 week start study 10 . Investigative drug study : participation evaluation investigational product 3 month study , calculate first day month follow last visit previous study 11 . Drug , alcohol : history drug alcohol abuse 12 . Plasma cholinesterase : Known plasma cholinesterase deficiency .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>